See more : Sedania Innovator Berhad (0178.KL) Income Statement Analysis – Financial Results
Complete financial analysis of Fiore Cannabis Ltd. (FIORF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Fiore Cannabis Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Shenzhen Changfang Group Co., Ltd. (300301.SZ) Income Statement Analysis – Financial Results
- Fresnillo plc (FNLPF) Income Statement Analysis – Financial Results
- OppFi Inc. (OPFI) Income Statement Analysis – Financial Results
- Sato Shoji Corporation (8065.T) Income Statement Analysis – Financial Results
- Shanghai Zhonggu Logistics Co., Ltd. (603565.SS) Income Statement Analysis – Financial Results
Fiore Cannabis Ltd. (FIORF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://fiorecannabis.com
About Fiore Cannabis Ltd.
Fiore Cannabis Ltd. cultivates, produces, and distributes medical and recreational marijuana in the United States. It also operates dispensary in California. The company was formerly known as Citation Growth Corp. and changed its name to Fiore Cannabis Ltd. in October 2020. The company was incorporated in 2007 and is headquartered in Kelowna, Canada.
Metric | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.15M | 2.27M | 1.46M | 0.00 | 383.90K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 2.44M | 1.72M | 888.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 711.00K | 549.00K | 572.00K | 0.00 | 383.90K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | 22.57% | 24.21% | 39.18% | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 5.76M | 9.46M | 21.49M | 17.40M | 9.89M | 2.50M | 255.65K | 56.56K | 52.10K | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 924.00 | 20.27K | 0.00 | 0.00 | 0.00 |
SG&A | 5.76M | 9.46M | 21.49M | 17.40M | 9.89M | 2.50M | 275.92K | 56.56K | 52.10K | 0.00 |
Other Expenses | 0.00 | 0.00 | -702.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 6.44M | 10.19M | 22.32M | 17.69M | 10.15M | 2.51M | 276.49K | 56.56K | 52.10K | 0.00 |
Cost & Expenses | 8.88M | 11.91M | 23.21M | 17.69M | 10.15M | 2.51M | 276.49K | 56.56K | 52.10K | 0.00 |
Interest Income | 0.00 | 0.00 | 0.00 | 3.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 1.28M | 2.14M | 969.00K | 318.00K | 108.14K | 13.55K | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 1.61M | 4.19M | 284.20K | 216.84K | 2.77K | 2.77K | 578.00 | -86.84K | 0.00 | 0.00 |
EBITDA | -4.91M | 5.13M | -17.90M | -18.10M | -9.66M | -2.50M | -275.92K | -143.40K | -52.10K | 0.00 |
EBITDA Ratio | -155.78% | 226.06% | -1,226.10% | 0.00% | -2,516.98% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -5.73M | -10.89M | -21.75M | -17.69M | -9.77M | -2.51M | -296.49K | -56.56K | -52.10K | 0.00 |
Operating Income Ratio | -181.94% | -480.16% | -1,489.73% | 0.00% | -2,544.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | -376.00K | -25.49M | -6.63M | -2.73M | -111.87K | -775.34K | -4.35M | 86.84K | 0.00 | 0.00 |
Income Before Tax | -8.18M | -37.44M | -29.42M | -20.74M | -9.99M | -3.30M | -4.63M | 30.28K | -52.10K | 0.00 |
Income Before Tax Ratio | -259.65% | -1,650.84% | -2,015.27% | 0.00% | -2,601.63% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 125.00K | 765.00K | 710.00K | -763.00K | -3.73K | 13.55K | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | -8.85M | -39.96M | -29.42M | -20.74M | -9.99M | -3.30M | -4.63M | 30.28K | -52.10K | 0.00 |
Net Income Ratio | -280.89% | -1,761.86% | -2,015.27% | 0.00% | -2,601.63% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -0.06 | -0.43 | -0.65 | -0.89 | -0.72 | -0.36 | -0.68 | 0.04 | -0.01 | 0.00 |
EPS Diluted | -0.06 | -0.43 | -0.65 | -0.89 | -0.72 | -0.36 | -0.68 | 0.04 | -0.01 | 0.00 |
Weighted Avg Shares Out | 152.18M | 93.96M | 45.52M | 23.17M | 13.87M | 9.15M | 6.83M | 790.82K | 8.84M | 0.00 |
Weighted Avg Shares Out (Dil) | 152.18M | 93.96M | 45.52M | 23.17M | 13.87M | 9.15M | 6.83M | 790.82K | 8.84M | 0.00 |
Fiore Cannabis Closes Second and Final Tranche of Private Placement
Fiore Cannabis Closes First Tranche of Private Placement
Fiore Cannabis Announces Virtual AGM Details
Fiore Cannabis Announces Preliminary Revenue Performance for First Quarter 2021
Fiore Cannabis Announces Presentation at KCSA Cannabis Investor Conference
Fiore Cannabis Highlights Strong Cannabis Sales Surge in Nevada Market Still Recovering from Impacts of Pandemic
Fiore Cannabis Announces Private Placement to Fuel Expansion in U.S. Markets
Fiore Cannabis Directs Focus on Core U.S. Assets and Turnaround Position
Fiore Cannabis Announces Sale of Surplus Cannabis Licence to Fund Expansion of Apex Cultivation Facility
Fiore Cannabis Continues Strategic Program to Refocus on Core Assets
Source: https://incomestatements.info
Category: Stock Reports